Research and methods −Artificial intelligence (AI) is opening up new possibilities for public health research. At the Robert Koch Institute (RKI), AI is used in research to be able to analyse health data more efficiently, predict disease outbreaks more accurately and better support evidence-based …
The COVRIIN+ expert group consists of leading representatives from the Deutsche Interdisziplinäre Vereinigung für Intensiv- und Notfallmedizin e.V. (DIVI), Deutsche Gesellschaft für Infektiologie e.V. (DGI), Deutsche Gesellschaft für Anästhesiologie and Intensivmedizin (DGAI), Deutsche Gesellschaft …
Since September 2019, people with statutory health insurance (SHI) who are at substantial risk of HIV infection have been entitled to coverage of HIV pre-exposure prophylaxis (PrEP). PrEP is an HIV prevention method in which HIV-negative people take a drug that has been approved for HIV therapy for …
The aim of the AntibioResDE (Antibiotic Resistance in Germany) project is to provide up-to-date information on antibiotic resistance in Germany on an electronic platform in order to simplify access to resistance data for clinical practice. AntibioResDE can thus help to prevent the development of …
Major biological incidents are rare. However, the consequences for public health may be severe if hazardous biological agents are released. Recognising, assessing and managing these events presents challenges for all responsible parties, including the police, fire brigade and public health services. …
Our team is responsible for the coordination, training and auditing of all 16 accredited laboratories of the RKI. We integrate the necessary interfaces to ensure that quality management is not only anchored in theory, but is actively implemented and continuously developed.The Quality Management …
From March 2nd to March 7th, a ZIG 2 and ZIG 4 research scientists traveled to Guinea to collaborate with the Institut National de Santé Publique (INSP) as part of the Vaccine Readiness in Sub-Saharan Africa (VRSA) project. The project’s current phase focuses on hepatitis B prevalence and immunity …